Patent details

Basic Information

Publication number:

EP1658856

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP060026838

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Exendins for glucagon suppression

French Title of Invention:

Exendines destinés à la suppression du glucagon

German Title of Invention:

Exendine zur Glucagon Suppression

SPC Number:

Dates

Filing date:

14/01/2000

Grant date:

17/03/2010

EP Publication Date:

17/03/2010

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/05/2006

EP B1 Publication Date:

17/03/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/01/2011

Expiration date:

14/01/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/01/2000

 

 

Name:

Amylin Pharmaceuticals Inc.

Address:

9360 Towne Centre Drive, San Diego, CA 92121, United States (US)

Inventor

1

Name:

Gedulin Bronislava

Address:

United States (US)

2

Name:

Young Andrew

Address:

United States (US)

Priority

1

Priority Number:

116380 P

Priority Date:

14/01/1999

Priority Country:

United States (US)

2

Priority Number:

132017 P

Priority Date:

30/04/1999

Priority Country:

United States (US)

3

Priority Number:

175365 P

Priority Date:

10/01/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/22;

Filing date	Document type	Number of pages